Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Inclusion Criteria: * Able to read (or, if unable to read due to visual impairment, be read to verbatim by the person administering the informed consent form or a family member) and understand the informed consent form and willing to sign the informed consent form. * Signed informed consent form. * Men and women ≥ 18 years of age. * Willing, committed, and able to return for all clinic visits and complete all study-related procedures. * First diagnosed active subfoveal or juxtafoveal (within 1 to 199 μm of the center of the fovea) CNV secondary to chorioretinitis as defined by leakage on FA * Transparent optical media and possibility to mydriasis. * Best corrected visual acuity at least 20/100 Equivalent of Snellen (ETDRS). Exclusion Criteria: * Ocular media of insufficient quality to obtain fundus and OCT images in the study eye * Recurrent CNV in the study eye * History or presence of CNV with an origin other than chorioretinitis in the study eye * Ocular inflammation or external ocular inflammation in the study eye * Concurrent disease in the study eye that would compromise BCVA or require medical or surgical intervention during the study period * Any ocular disorder in the study eye that, in the opinion of the investigator, may confound interpretation of the study results * Significant scarring or atrophy in the fovea that indicates substantial irreversible vision loss in the study eye * Evidence at examination of infectious blepharitis, keratitis, scleritis, or conjun…